October 2023

A listing of the individual articles included in the Jurisdiction F Medicare A News bulletin dated October 2023 is provided. Each article title functions as a hyperlink to a specific article.

paginationType regular
Articles Source
IRF Annual Update: Prospective Payment System (PPS) PRICER Changes for Fiscal Year (FY) 2024 CR13266
January 2023 Quarterly ASP Medicare Part B Drug Pricing Files and Revisions to Prior Quarterly Pricing Files CR12925
Limitation on Recoupment of Overpayments CR11262
MACs to Fully Activate Edits for Practice Location Address Requirements on August 1
Manual Update Pub. 100-02 Medicare Benefit Policy, Chapter 15, Section 110.8 DMEPOS Benefit Category Determinations CR13028
Medicare Basics: Three Medicare Basics On-Demand Tutorials Available
Medicare Part A SNF PPS Pricer Update FY 2024 CR13270
Medicare Policy Updates for Dental Services as Finalized in the CY 2023 MPFS Final Rule CR13181
MLN Connects - August 10, 2023
MLN Connects - August 17, 2023
MLN Connects - August 24, 2023
MLN Connects - August 3, 2023
MLN Connects - August 31, 2023
MLN Connects - December 1, 2022
MLN Connects - December 15, 2022
MLN Connects - December 22, 2022
MLN Connects - December 8, 2022
MLN Connects - February 16, 2023
MLN Connects - February 2, 2023
MLN Connects - February 23, 2023
MLN Connects - February 9, 2023
MLN Connects - January 12, 2023
MLN Connects - January 19, 2023
MLN Connects - January 26, 2023
MLN Connects - January 5, 2023
MLN Connects - January 9, 2023 - CMS Awards 200 New Medicare-funded Residency Slots to Hospitals Serving Underserved Communities
MLN Connects - July 13, 2023
MLN Connects - July 20, 2023
MLN Connects - July 27, 2023
MLN Connects - July 6, 2023
MLN Connects - September 14, 2023
MLN Connects - September 21, 2023
MLN Connects - September 28, 2023
MLN Connects - September 7, 2023
MLN Connects Newsletter: 5 Final FY 2024 Payment Rules - Aug 1, 2023
MLN Connects Newsletter: Broader Medicare Coverage of Leqembi Available Following FDA Traditional Approval - July 7, 2023
MLN Connects Newsletter: COVID-19 Public Health Emergency (PHE) New Overview Fact Sheet - Feb 27, 2023
MLN Connects Newsletter: COVID-19: Updated mRNA Vaccines for Patients 6 Months & Older - Sept 14, 2023
MLN Connects Newsletter: PFS & OPPS/ASC Proposed Payment Rules - July 13, 2023
MLN Connects Newsletter: Prescription Drug Inflation Rebate Program Guidance - February 9, 2023
MLN Connects Newsletter: Public Health Emergency 1135 Waivers: Updated Guidance for Providers - Feb 23, 2023
MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers (DL39688) and Billing and Coding: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers (DA59515) - Published for Review and Comments
MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (L36186) - R12 - Effective July 06, 2023
MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) (L36159) - R5 - Effective July 20, 2023
MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis (L39469) Final LCD - Effective October 15, 2023
MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy (DL39680) and Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy (DA59507) - Published for Review and Comments
MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (L39007) - R1 - Effective July 27, 2023
MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules (DL39684) and Billing and Coding: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules (DA59511) - Published for Review and Comments
MolDX: Molecular Testing for Solid Organ Allograft Rejection (DL38671) and Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection (DA58170) - Published for Review and Comments
MolDX: myPath® Melanoma Assay L37881 Retirement - Effective August 06, 2023
— 50 Items per Page
Showing 51 - 100 of 132 results.